We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
AUM
$266M
AUM Growth
-$519M
Cap. Flow
-$520M
Cap. Flow %
-195.59%
Top 10 Hldgs %
24.71%
Holding
657
New
41
Increased
1
Reduced
224
Closed
243
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRIVW
376
DELISTED
B. Riley Principal 250 Merger Corp. Warrant
BRIVW
$1.92K ﹤0.01%
28,968
-12,214
-30% -$925
LBBBW
377
DELISTED
Lakeshore Acquisition II Corp. Warrants
LBBBW
$1.87K ﹤0.01%
62,355
-62,377
-50% -$2.5K
MNTSW icon
378
Momentus Inc Warrant
MNTSW
$122
$1.84K ﹤0.01%
45,189
-51,120
-53% -$3.81K
GENQW
379
DELISTED
Genesis Unicorn Capital Corp. Warrants
GENQW
$1.84K ﹤0.01%
19,408
-23,429
-55% -$1.99K
MOBXW icon
380
Mobix Labs Warrants
MOBXW
$742K
$1.84K ﹤0.01%
73,574
-5,152
-7% -$468
FMIVW
381
DELISTED
Forum Merger IV Corporation Warrant
FMIVW
$1.75K ﹤0.01%
13,981
-51,107
-79% -$5.15K
ADALW
382
DELISTED
Anthemis Digital Acquisitions I Corp Warrant
ADALW
$1.71K ﹤0.01%
42,715
-23,120
-35% -$1.1K
MDGSW
383
DELISTED
Medigus Ltd. Series C Warrant
MDGSW
$1.64K ﹤0.01%
+55,486
New +$3.98K
SKYAW
384
DELISTED
Skydeck Acquisition Corp. Warrants
SKYAW
$1.59K ﹤0.01%
48,799
-15,181
-24% -$950
SHAP.WS
385
DELISTED
Spree Acquisition Corp. 1 Limited Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SHAP.WS
$1.58K ﹤0.01%
52,335
-4,500
-8% -$167
QOMOW
386
DELISTED
Qomolangma Acquisition Corp. Warrant
QOMOW
$1.5K ﹤0.01%
50,000
TRAQ.WS
387
DELISTED
Trine II Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
TRAQ.WS
$1.45K ﹤0.01%
28,978
-2,789
-9% -$219
SRZNW icon
388
Surrozen Inc Warrant
SRZNW
$69.7K
$1.41K ﹤0.01%
14,122
-500
-3% -$41
HMACW
389
DELISTED
Hainan Manaslu Acquisition Corp. Warrant
HMACW
$1.36K ﹤0.01%
25,000
IPVIW
390
DELISTED
InterPrivate IV InfraTech Partners Inc. Warrant
IPVIW
$1.36K ﹤0.01%
15,077
-2,400
-14% -$194
CHEKZ
391
DELISTED
Check-Cap Ltd. Series C Warrant
CHEKZ
$1.34K ﹤0.01%
122,964
NCACW
392
DELISTED
Newcourt Acquisition Corp Warrant
NCACW
$1.32K ﹤0.01%
39,649
-99,747
-72% -$4.24K
BPACW
393
DELISTED
Bullpen Parlay Acquisition Company Warrant
BPACW
$1.27K ﹤0.01%
35,650
-1,700
-5% -$96
EUCRW
394
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$1.25K ﹤0.01%
30,854
-43,223
-58% -$2.98K
IQMDW
395
DELISTED
Intelligent Medicine Acquisition Corp. Warrant
IQMDW
$1.07K ﹤0.01%
23,302
-31,098
-57% -$1.34K
AFARW
396
DELISTED
Aura FAT Projects Acquisition Corp Warrant
AFARW
$1.06K ﹤0.01%
25,000
CCAIW
397
DELISTED
Cascadia Acquisition Corp. Warrant
CCAIW
$1.01K ﹤0.01%
10,000
-11,600
-54% -$963
TVGNW icon
398
Tevogen Inc. Warrant
TVGNW
$8.42M
$993 ﹤0.01%
19,732
-43,200
-69% -$2.39K
SPCMW
399
DELISTED
Sound Point Acquisition Corp I, Ltd Warrant
SPCMW
$989 ﹤0.01%
12,167
-4,533
-27% -$550
INTEW
400
DELISTED
Integral Acquisition Corporation 1 Warrants
INTEW
$978 ﹤0.01%
29,097
-800
-3% -$30

Similar funds

CVI Holdings's Q1 2023 Portfolio in Review

As of Q1 2023, CVI Holdings held 657 positions worth $266M, down 66% from $784M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

CVI Holdings withdrew a net $520M in Q1 2023, closing 243 positions and reducing 224 holdings. Its most notable exit was ImmunityBio, an estimated $38.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 68% of assets, up from 64% a quarter earlier, followed by Healthcare and Technology.

Against the trend, CVI Holdings opened a new position in GeneDx Holdings worth $3.56M.

  • CVI Holdings's largest Q1 2023 buy was GeneDx Holdings: 295,706 shares worth $3.56M.
  • CVI Holdings added most to TPG Pace Beneficial II Corp. in Q1 2023, an estimated $82.2K increase.
  • CVI Holdings's biggest Q1 2023 reduction was RTB Digital, cutting an estimated $1.96M.
  • CVI Holdings fully exited ImmunityBio in Q1 2023, selling an estimated $38.6M.
  • CVI Holdings's ten largest holdings make up 25% of its $266M portfolio in Q1 2023.
  • CVI Holdings opened 41 new positions and closed 243 in Q1 2023.
  • CVI Holdings's portfolio value fell 66% quarter-over-quarter to $266M.

Based on CVI Holdings's 13F filing for Q1 2023, filed 16 May 2023.